Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Matrix Analytics is a healthcare technology company that specializes in clinical decision support and data management for lung cancer screening and lung nodule programs. Its flagship platform, LungDirect, automates the tracking and management of patients with incidental lung nodules or those undergoing screening, ensuring adherence to clinical guidelines like Fleischner and Lung-RADS. By integrating with electronic health records and imaging systems, the company helps health systems improve patient outcomes through early detection and streamlined workflows. Matrix Analytics serves oncology and pulmonology departments by providing tools for data collection, reporting, and quality assurance. The company was acquired by PenRad Technologies in 2020 to enhance their suite of diagnostic imaging and tracking solutions.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Matrix Analytics.